Global Tissue Diagnostics TDx Market Overview
Tissue diagnostics is analysing and testing specific tissue samples in order to understand the biological background of diseases. They are used to detect certain medical problems including as cancer and inflammatory disorders, as well as indicate the precise type and degree of malignancy, which aids in the identification of potential causes and treatment choices. Tissue diagnostics are very accurate, low-cost, and can be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling. The overall share of the geriatric population is currently growing steadily over the world due to decreased fertility rates and higher life expectancy. Because older persons are more susceptible to chronic diseases and hence require frequent check-ups and diagnoses, this is a critical element contributing to market growth. Aside from that, changes in eating habits, increased alcohol consumption, and decreased physical activity have all contributed to an increase in the prevalence of a variety of lifestyle diseases. Furthermore, the increased occurrence of many forms of malignancies in people of all ages has resulted in an increase in demand for these diagnostic services. The Tissue Diagnostics (TDx) Market accounted for US$ 5699.59 million in 2020 and is estimated to be US$ 13814.7 million by 2030 and is anticipated to register a CAGR of 9.30%.
Global Tissue Diagnostics TDx Market Dynamics
Increased occurrence of many forms of malignancies in people boost the market growth
Tissue diagnostics is a vital tool for diagnosing cancer patients, as well as in pharmacological research. Tissue-based diagnostic tests play an important part in current medical practise, and they are used to diagnose a variety of disorders using a variety of tools and consumables. Tissue diagnostic goods, such as tools and consumables, must meet stringent quality standards in order to be used in tissue-based diagnostic procedures. Furthermore, the tissue diagnostics market is highly consolidated, with only a few significant competitors controlling the whole market. New entrants to this sector face significant entry hurdles due to stringent regulatory requirements and a high degree of consolidation. Modest and mid-sized businesses make up a small portion of the market, but their commercial interests are diverse.
Global Tissue Diagnostics TDx Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The Global Tissue Diagnostics (TDx) Market is segmented based on product, technology, disease, end-user and region.
Based on Product, the target market is segmented into Antibodies, Kits, Slide Staining System, Tissue Processing System. On the basis of Technology, the Global Tissue Diagnostics (TDx) Market is segmented into ISH, IHC, Special Staining. On the basis of Disease, the Global Tissue Diagnostics (TDx) Market is segmented into Breast Cancer, NSCLC, Lymphoma. Based on End-User, the target market is segmented into Hospitals, Research Laboratories.
Regional Insights:
Source: Prophecy Market Insights
On region the Global Tissue Diagnostics (TDx) Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The tissue diagnostic market in North America, dominates the market during the forecast year. North America had the biggest market share in 2019, followed by Europe. The growth of the tissue diagnostic market in North America is being fueled by easy access to advanced technologies, government initiatives for cancer screening, favourable reimbursement scenarios for pathology diagnostic tests, rising healthcare expenditures, and high-quality infrastructure for hospitals and clinical laboratories in this region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Technology- ISH, IHC, Special Staining By Product- Antibodies, Kits, Slide Staining System, Tissue Processing System By Disease- Breast Cancer, NSCLC, Lymphoma By End-user- Hospitals, Research Laboratories |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Tissue Diagnostics (TDx) Market report based on Technology, Product, Disease, End-User and region.
Global Tissue Diagnostics (TDx) Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Tissue Diagnostics TDx Market Key Players
The prominent players operating in the Global Tissue Diagnostics (TDx) Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), and Dipath S.P.A. (Italy).
Global Tissue Diagnostics TDx Market Company Profile
- Roche
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Agilent Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGAA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medite GMBH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Jinhua Yidi Medical Appliance Co.Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Tissue Diagnostics TDx Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Electric Vehicle Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technology
- Market Snippet, By Product
- Market Snippet, By End-User
- Market Snippet, By End-User
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Tissue Diagnostics (TDx) Market, By Technology, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- ISH
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- IHC
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Special Staining
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Tissue Diagnostics (TDx) Market, By Product, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Antibodies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Slide Staining System
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Tissue Processing System
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Tissue Diagnostics (TDx) Market, By Disease, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Breast Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- NSCLC
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Lymphoma
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Tissue Diagnostics (TDx) Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Research Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Tissue Diagnostics (TDx) Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Roche
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Agilent Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGAA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medite GMBH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Jinhua Yidi Medical Appliance Co.Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Global Tissue Diagnostics (TDx) Market is segmented based on technology, product, disease, end-user and region.
Increased occurrence of many forms of malignancies in people is major factor driving the market.
During the forecast period, North America is expected to dominate the market.
The prominent players operating in the Global Tissue Diagnostics (TDx) Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), and Dipath S.P.A. (Italy).